| 09:00-09:30 |
Frank Madeo (Graz, Austria) |
| |
Spermidine for a long life |
| 09:30-09:45 |
Joel Beaudouin (Heidelberg, Germany) |
| |
Spatiotemporal characterization of caspase activity in single cells |
| 09:45-10:00 |
Nieves Peltzer (Lausanne, Switzerland) |
| |
A caspase- and RasGAP fragment N-activated survivin-dependent protective response in the skin |
| 10:00-10:30 |
Ana Maria Cuervo (New York, USA) |
| |
Selective autophagy: fueling and cleaning in the same compartment |
| |
|
| 10:30-11:00 |
Coffee |
| |
|
| 11:00-11:30 |
Cosima Baldari (Siena, Italy) |
| |
p66Shc: a novel player in lymphocyte apoptosis |
| 11:30-12:00 |
Judy Lieberman (Boston, USA) |
| |
Granzyme A-mediated cell death: using proteomics to dissect the anatomy of a murder |
| 12:00-12:25 |
Kris Gevaert (Ghent, Belgium) |
| |
Positional proteomics in cell death research |
| 12:25-12:55 |
Marion MacFarlane (Leicester, UK) |
| |
Selectively Targeting Death Receptor Signalling in Cancer |
| 12.55-13.10 |
Alexander Pintzas (Athens, Greece) |
| |
Oncogenes can sensitise tumour cells to TRAIL induced apoptosis: The paradigm of RAS and BRAF oncogenes in colorectal tumours, from models to the clinic |
| 16:00-16:30 |
Peter Krammer (Heidelberg, Germany) |
| |
Cancer, death and the immune system |
| 16:30-16:45 |
Tom Cotter (Cork, Ireland) |
| |
Looking Cell Death in the Eye |
| 16:45-17:00 |
Sven Horke (Mainz, Germany) |
| |
Pursuing Redox-balance modification: PON2 as a new putative anti-tumor target |
| 17:00-17:15 |
Catharina Svanborg (Lund, Sweden) |
| |
HAMLET kills carcinoma cells but spares healthy, differentiated cells. Molecular basis of the tumoricidal effect |
| |
|
| 17.15-17.25 |
Poster awards |
| |
|
| 17:25-18:25 |
ECDO Honorary Lecture: Dr. Guido Kroemer (Villejuif, France) |
| |
The desirable death .... of the cancer cell |
| |
|
| 18:30-19:00 |
ECDO General Assembly (for ECDO members) |
| |
|